Loading article…
The S&P 500 rebounded in May 2025 with a 6.15% gain. Discover the top-performing stocks and the healthcare companies that faced significant declines.
The S&P 500 staged a significant recovery in May 2025, climbing 6.15% after a turbulent April that saw the index briefly enter bear market territory [1, 3]. While the broader market rally resulted in positive returns for 346 of the index's 500 constituents, nearly 30% of the stocks tracked by the index ended the month in the red [1, 3].
Key takeaways
The month’s top performers were driven by strategic acquisitions and the ongoing demand for AI-related infrastructure [3]. NRG Energy surged over 42% after reporting first-quarter adjusted earnings of $2.62 per share and announcing the acquisition of LS Power’s “Premier Power” portfolio [3]. Similarly, Constellation Energy rose 37% as it positioned itself in the clean energy sector, aided by government support for nuclear energy and a partnership to supply power to Microsoft’s AI infrastructure [3]. Seagate Technology also saw a nearly 30% increase, as cloud providers and AI data centers drove demand for its high-capacity storage solutions [3].
In contrast, the healthcare sector faced significant headwinds, with UnitedHealth Group emerging as the worst-performing stock in the S&P 500 for May [1, 2]. The company’s stock plunged 26.6% following the abrupt resignation of CEO Andrew Witty and the withdrawal of its full-year earnings outlook due to surging Medicare Advantage costs [1, 3]. UnitedHealth also faced external scrutiny regarding allegations of Medicare fraud and improper bonus payments to nursing homes, claims the company has refuted [1]. Regeneron Pharmaceuticals also struggled, losing 18.2% of its value after its experimental drug, itepekimab, failed in a phase 3 trial, leading investors to anticipate a multi-year delay for the product [1].
The divergence in performance between energy-focused companies and healthcare giants highlights how sector-specific news can dictate market movement even during a broad index recovery [3]. For investors, the volatility in healthcare—particularly regarding Medicare Advantage utilization and clinical trial outcomes—remains a critical area of focus [1, 3]. Looking ahead, UnitedHealth’s second-quarter earnings report, scheduled for July 29, is expected to provide further clarity on the company’s path toward its goal of returning to growth in 2026 [1].
Coverage is mostly measured — 143 of 165 reports stay neutral.
Every Monday — the token unlocks, Fed dates & catalysts set to move crypto and markets this week. So you’re never blindsided.
Free · 3-min read · one-click unsubscribe
AI-assisted synthesis by the TrendWatcher Editorial Desk · sourced from 3 outlets · May 31, 2026 · How we report
The 10-year Treasury yield is above 4.7%, and analysts note that a sustained rise toward 5% could negatively impact the stock market because higher yields can reduce equity demand.
Utilities have underperformed, lagging the S&P 500 by roughly 3.3 percentage points year‑to‑date, partly due to regulatory and policy uncertainties.
Over 87% of the S&P 500 companies that have reported earnings so far have exceeded analysts' forecasts, according to FactSet.
On average, companies that beat forecasts have slipped about 0.2% the following day, which is weaker than the typical 0.6% gain seen in prior quarters.
Analysts describe the market as highly rotational rather than corrective, emphasizing the need to monitor consumer‑facing firms as energy prices and borrowing costs rise.